Track the 대화제약 stock price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are listed on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 대화제약 has recorded 134 insider filings. Market capitalisation: €201.8bn. The latest transaction was disclosed on 22 September 2026 (Purchase). Among the most active insiders: 김수지. The full history is free.
131
Insider Decl.
n/a
Thresholds
€69,224
18 ops.
Buy Volume
€29,868
35 ops.
Sell Volume
31Σ signal
Buys €69,224€29,868 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 21,895 of 29,156 companies
34.4
score / 100
Value
34
Quality
35
FCF yld0.3%
Earn yld0.8%
EV/EBITDA19.4x
ROE6.1%
Gross mgn33%
Net mgn1.2%
Debt/EBITDA6.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
대화제약 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on the development and distribution of pharmaceutical products.